Award
NIH Reporter #1R43AR083322-01A1
MuscleInk: A multifunctional colloidal scaffold for the treatment of muscle loss
Recipient
Not specified
Award Amount
$295,481.00
Ceiling
$295,481.00
Awarded
August 19, 2024
Identifier
1R43AR083322-01A1
Development and testing of MuscleInk, an injectable scaffold for muscle regeneration targeting volumetric muscle loss injuries, including biocompatibility and bioactivity studies in vitro and in animal models.
Description
This NIH SBIR project aims to develop and test a novel injectable scaffold for muscle regeneration, with potential clinical application for volumetric muscle loss injuries. The project includes characterization, in vitro and in vivo testing, and regulatory pathway planning.